Biggest News Aggregation in the World
📰 Dc News

Page 228 - Dc News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Dc. Real-time updates on events, politics, business and more.

Look Beyond GPOs for a New World of Cost Savings

There’s a common belief in the healthcare industry that partnering with Group Purchasing Organizations (GPOs) means that most or all non-clinical purchases are covered by the contract. It almost sounds too good to be true: GPOs have all the answers for all your procurement needs. Finally, a one-stop shop for all your procurement solutions! Unfortunately, this is far from reality. In reality, GPOs only cover around 12-25% of non-clinical spend. This means that over 75% of non-clinical expe...
Group Purchasing Organizations Gpos Group Purchasing Organizations Weight Loss Medical Devices Healthcare Innovation Medcity News

Cohere Health Snags $50M to Speed Up Prior Authorization

Prior authorization software startup Cohere Health raised $50 million on Thursday, bringing its total funding to $106 million. The need for software to streamline the prior authorization process is perhaps more evident than ever given CMS’ new rule on the matter.
Siva Namasivayam Evolent Health Children Health Insurance Program Boston Based Cohere Health Deerfield Management Define Ventures

Coordination of Benefits: An Overlooked Pillar of Medicaid Programs

Coordination of benefits is a critical pillar of the Medicaid program as it ensures the efficient use of resources, prevents overutilization, promotes equity in resource distribution, mitigates fraud and abuse, contributes to program longevity and ultimately enhances healthcare access for beneficiaries.
United State Weight Loss Medical Devices Healthcare Innovation Medcity News Medcity News

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Takeda Puts Up $300M to Partner on Protagonist Drug for Rare Blood Disease

Protagonist Therapeutics' rusfertide could have preliminary data next year from its Phase 3 test in polycythemia vera. If the peptide drug wins FDA approval in this rare blood disorder, the partners will share in U.S. commercialization while Takeda is responsible for the drug in the rest of the world.
United States Takeda Adzynma Dinesh Patel Julie Kim American Society Of Hematology Ionis Pharmaceuticals

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science